Gill Capital Partners »

Nautilus Biotechnology shares owned by Gill Capital Partners

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Gill Capital Partners from 13F filings

Historical chart of Gill Capital Partners investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Gill Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Gill Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $970 250 3.88

More positions owned by Gill Capital Partners

Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Growth Etf Etf (VUG)
Vanguard Value Etf Etf (VTV)
Schwab Us Large Cap Growth Etf Etf (SCHG)
Jpmorgan Active Value Etf Etf (JAVA)
Invesco Bulletshares 2029 Corporate Bond Etf Etf (BSCT)
Vanguard Mid Cap Etf (VO)
Schwab Us Large Cap Value Etf Etf (SCHV)
Invesco Bulletshares 2032 Corporate Bond Etf Etf (BSCW)
Kroger Stock (KR)
Schwab International Equity Etf Etf (SCHF)
Schwab Us Mid-cap Etf Etf (SCHM)
Powershares Qqq Tr Etf (QQQ)
Vanguard Small Cap Etf Etf (VB)
Schwab Etfs- Us Small-cap Etf Etf (SCHA)

View all positions for Gill Capital Partners

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
Vanguard Group
Vanguard Capital Management
Hartland & Co
Comprehensive Financial Management
Amazon
Millennium Management
Clarius
_Sentinel Trust Company, LBA______________
Acadian Asset Management
Tikvah Management
Geode Capital Management

View all funds holding Nautilus Biotechnology